Announcing Webinar for Risk-Based Monitoring Guidance

Announcing Webinar for Risk-Based Monitoring Guidance FDA's Critical Path Initiative is launching a Guidance Webinar series to foster collaboration and transparency in the development of guidance documents through direct outreach to affected stakeholders. This first-in-a-series of planned Guidance Webinars, scheduled for October 24, 2011 from 11 a.m. to noon, will include an overview of the draft guidance Oversight of Clinical Investigations – A Risk-Based Approach to Monitoring and a real-time question and answer session with its primary authors. Archived webinars will be available on FDA's website .  
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM269919.pdf

Guidance Webinars Online-Access Instructions
http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/ucm276211.htm
Critical Path Initiative Homepage
http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/default.htm
Weekly Media Tip Sheet
http://www.fda.gov/NewsEvents/Newsroom/WeeklyMediaTipSheet/default.htm